1	RADIOACTIVE DIAGNOSTIC AGENT [EPC]
2	POSITRON EMITTING ACTIVITY [MOA]
3	ANTIARRHYTHMIC [EPC]
4	CYTOCHROME P450 2D6 INHIBITOR [EPC]
5	CYTOCHROME P450 2D6 INHIBITORS [MOA]
6	ANDROGEN [EPC]
7	ANDROGEN RECEPTOR AGONISTS [MOA]
8	ANDROSTANES [CHEMICAL/INGREDIENT]
9	SEROTONIN REUPTAKE INHIBITOR [EPC]
10	SEROTONIN UPTAKE INHIBITORS [MOA]
11	NOREPINEPHRINE REUPTAKE INHIBITOR [EPC]
12	NOREPINEPHRINE UPTAKE INHIBITORS [MOA]
13	ATYPICAL ANTIPSYCHOTIC [EPC]
14	SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITOR [EPC]
15	ESTROGEN AGONIST/ANTAGONIST [EPC]
16	SELECTIVE ESTROGEN RECEPTOR MODULATORS [MOA]
17	PHOSPHODIESTERASE 5 INHIBITOR [EPC]
18	PHOSPHODIESTERASE 5 INHIBITORS [MOA]
19	HMG-COA REDUCTASE INHIBITOR [EPC]
20	HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS [MOA]
21	DECREASED PLATELET AGGREGATION [PE]
22	P2Y12 PLATELET INHIBITOR [EPC]
23	P2Y12 RECEPTOR ANTAGONISTS [MOA]
24	NUCLEIC ACID SYNTHESIS INHIBITORS [MOA]
25	NUCLEOSIDE METABOLIC INHIBITOR [EPC]
26	INSULIN [CHEMICAL/INGREDIENT]
27	INSULIN ANALOG [EPC]
28	FOLATE ANALOG METABOLIC INHIBITOR [EPC]
29	FOLIC ACID METABOLISM INHIBITORS [MOA]
30	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 ANTAGONIST [EPC]
31	VEGFR2 INHIBITORS [MOA]
32	PARATHYROID HORMONE [CHEMICAL/INGREDIENT]
33	PARATHYROID HORMONE ANALOG [EPC]
34	INSULIN [EPC]
35	CORTICOSTEROID [EPC]
36	CORTICOSTEROID HORMONE RECEPTOR AGONISTS [MOA]
37	T LYMPHOCYTE COSTIMULATION ACTIVITY BLOCKADE [PE]
38	SELECTIVE T CELL COSTIMULATION BLOCKER [EPC]
39	CD80-DIRECTED ANTIBODY INTERACTIONS [MOA]
40	CD86-DIRECTED ANTIBODY INTERACTIONS [MOA]
41	KINASE INHIBITOR [EPC]
42	PROTEIN KINASE INHIBITORS [MOA]
43	ANTIMETABOLITE [EPC]
44	UREA [CHEMICAL/INGREDIENT]
45	FACTOR XA INHIBITOR [EPC]
46	FACTOR XA INHIBITORS [MOA]
47	SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR [EPC]
48	SODIUM-GLUCOSE TRANSPORTER 2 INHIBITORS [MOA]
49	HEPATITIS B VIRUS NUCLEOSIDE ANALOG REVERSE TRANSCRIPTASE INHIBITOR [EPC]
50	NUCLEOSIDE ANALOG [CHEMICAL/INGREDIENT]
51	NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS [MOA]
52	HUMAN IMMUNODEFICIENCY VIRUS NUCLEOSIDE ANALOG REVERSE TRANSCRIPTASE INHIBITOR [EPC]
53	DECREASED CYTOKINE ACTIVITY [PE]
54	SELECTIVE T CELL COSTIMULATION MODULATOR [EPC]
55	RECOMBINANT FUSION PROTEINS [CHEMICAL/INGREDIENT]
56	MONOBACTAM ANTIBACTERIAL [EPC]
57	MONOBACTAMS [CHEMICAL/INGREDIENT]
58	CTLA-4-DIRECTED BLOCKING ANTIBODY [EPC]
59	CTLA-4-DIRECTED ANTIBODY INTERACTIONS [MOA]
60	INCREASED T LYMPHOCYTE ACTIVATION [PE]
61	HIV PROTEASE INHIBITORS [MOA]
62	PROTEASE INHIBITOR [EPC]
63	CYTOCHROME P450 3A INHIBITORS [MOA]
64	CYTOCHROME P450 3A INHIBITOR [EPC]
65	P-GLYCOPROTEIN INHIBITORS [MOA]
66	ORGANIC ANION TRANSPORTING POLYPEPTIDE 1B1 INHIBITORS [MOA]
67	ORGANIC ANION TRANSPORTING POLYPEPTIDE 1B3 INHIBITORS [MOA]
68	BREAST CANCER RESISTANCE PROTEIN INHIBITORS [MOA]
69	DIPEPTIDYL PEPTIDASE 4 INHIBITOR [EPC]
70	DIPEPTIDYL PEPTIDASE 4 INHIBITORS [MOA]
71	BIGUANIDE [EPC]
72	BIGUANIDES [CHEMICAL/INGREDIENT]
73	CYCLOOXYGENASE INHIBITORS [MOA]
74	NONSTEROIDAL ANTI-INFLAMMATORY COMPOUNDS [CHEMICAL/INGREDIENT]
75	NONSTEROIDAL ANTI-INFLAMMATORY DRUG [EPC]
76	CYTOMEGALOVIRUS NUCLEOSIDE ANALOG DNA POLYMERASE INHIBITOR [EPC]
77	DNA POLYMERASE INHIBITORS [MOA]
78	NUCLEOSIDE ANALOG ANTIVIRAL [EPC]
79	BENZODIAZEPINE [EPC]
80	BENZODIAZEPINES [CHEMICAL/INGREDIENT]
81	BISPHOSPHONATE [EPC]
82	DIPHOSPHONATES [CHEMICAL/INGREDIENT]
83	INTESTINAL LIPASE INHIBITOR [EPC]
84	LIPASE INHIBITORS [MOA]
85	ANTIMETABOLITE IMMUNOSUPPRESSANT [EPC]
86	INTERFERON ALPHA [EPC]
87	PEGINTERFERON ALFA-2A [CHEMICAL/INGREDIENT]
88	ERYTHROPOIESIS-STIMULATING AGENT [EPC]
89	ERYTHROPOIETIN [CHEMICAL/INGREDIENT]
90	INCREASED ERYTHROID CELL PRODUCTION [PE]
91	CEPHALOSPORIN ANTIBACTERIAL [EPC]
92	CEPHALOSPORINS [CHEMICAL/INGREDIENT]
93	INACTIVATED PNEUMOCOCCAL VACCINE [EPC]
94	ACTIVELY ACQUIRED IMMUNITY [PE]
95	VACCINES
96	INACTIVATED [CHEMICAL/INGREDIENT]
97	PNEUMOCOCCAL VACCINES [CHEMICAL/INGREDIENT]
98	CONJUGATE [CHEMICAL/INGREDIENT]
99	OREXIN RECEPTOR ANTAGONIST [EPC]
100	OREXIN RECEPTOR ANTAGONISTS [MOA]
101	ANGIOTENSIN CONVERTING ENZYME INHIBITOR [EPC]
102	ANGIOTENSIN-CONVERTING ENZYME INHIBITORS [MOA]
103	ANTIPARASITIC [EPC]
104	PEDICULICIDE [EPC]
105	5-ALPHA REDUCTASE INHIBITOR [EPC]
106	5-ALPHA REDUCTASE INHIBITORS [MOA]
107	HIV INTEGRASE INHIBITORS [MOA]
108	HUMAN IMMUNODEFICIENCY VIRUS INTEGRASE STRAND TRANSFER INHIBITOR [EPC]
109	SEROTONIN 1B RECEPTOR AGONISTS [MOA]
110	SEROTONIN 1D RECEPTOR AGONISTS [MOA]
111	SEROTONIN-1B AND SEROTONIN-1D RECEPTOR AGONIST [EPC]
112	VITAMIN D [CHEMICAL/INGREDIENT]
113	VITAMIN D [EPC]
114	PROTEASE-ACTIVATED RECEPTOR-1 ANTAGONIST [EPC]
115	PROTEASE-ACTIVATED RECEPTOR-1 ANTAGONISTS [MOA]
116	NEUROKININ 1 ANTAGONISTS [MOA]
117	SUBSTANCE P/NEUROKININ-1 RECEPTOR ANTAGONIST [EPC]
118	CYTOCHROME P450 3A4 INHIBITORS [MOA]
119	CYTOCHROME P450 2C9 INDUCERS [MOA]
120	HISTONE DEACETYLASE INHIBITOR [EPC]
121	HISTONE DEACETYLASE INHIBITORS [MOA]
122	ANGIOTENSIN 2 RECEPTOR ANTAGONISTS [MOA]
123	ANGIOTENSIN 2 RECEPTOR BLOCKER [EPC]
124	INCREASED DIURESIS [PE]
125	THIAZIDE DIURETIC [EPC]
126	THIAZIDES [CHEMICAL/INGREDIENT]
127	LEUKOTRIENE RECEPTOR ANTAGONIST [EPC]
128	LEUKOTRIENE RECEPTOR ANTAGONISTS [MOA]
129	PROGRAMMED DEATH RECEPTOR-1 BLOCKING ANTIBODY [EPC]
130	PROGRAMMED DEATH RECEPTOR-1-DIRECTED ANTIBODY INTERACTIONS [MOA]
131	CARBAPENEMS [CHEMICAL/INGREDIENT]
132	PENEM ANTIBACTERIAL [EPC]
133	DIPEPTIDASE INHIBITORS [MOA]
134	RENAL DEHYDROPEPTIDASE INHIBITOR [EPC]
135	CARBONIC ANHYDRASE INHIBITOR [EPC]
136	CARBONIC ANHYDRASE INHIBITORS [MOA]
137	ADRENERGIC BETA-ANTAGONISTS [MOA]
138	BETA-ADRENERGIC BLOCKER [EPC]
139	ECHINOCANDIN ANTIFUNGAL [EPC]
140	LIPOPEPTIDES [CHEMICAL/INGREDIENT]
141	AROMATIC AMINO ACID DECARBOXYLATION INHIBITOR [EPC]
142	DOPA DECARBOXYLASE INHIBITORS [MOA]
143	PROSTAGLANDIN ANALOG [EPC]
144	PROSTAGLANDIN RECEPTOR AGONISTS [MOA]
145	INCREASED PROSTAGLANDIN ACTIVITY [PE]
146	PROSTAGLANDINS [CHEMICAL/INGREDIENT]
147	INACTIVATED HUMAN PAPILLOMAVIRUS VACCINE [EPC]
148	PAPILLOMAVIRUS VACCINES [CHEMICAL/INGREDIENT]
149	LIVE ROTAVIRUS VACCINE [EPC]
150	ROTAVIRUS VACCINES [CHEMICAL/INGREDIENT]
151	LIVE
152	UNATTENUATED [CHEMICAL/INGREDIENT]
153	INACTIVATED HEPATITIS B VIRUS VACCINE [EPC]
154	HEPATITIS B VACCINES [CHEMICAL/INGREDIENT]
155	INACTIVATED HEPATITIS A VIRUS VACCINE [EPC]
156	HEPATITIS A VACCINES [CHEMICAL/INGREDIENT]
157	STANDARDIZED POLLEN ALLERGENIC EXTRACT [EPC]
158	INCREASED HISTAMINE RELEASE [PE]
159	CELL-MEDIATED IMMUNITY [PE]
160	INCREASED IGG PRODUCTION [PE]
161	POLLEN [CHEMICAL/INGREDIENT]
162	ALLERGENS [CHEMICAL/INGREDIENT]
163	LIVE ATTENUATED MEASLES VIRUS VACCINE [EPC]
164	ATTENUATED [CHEMICAL/INGREDIENT]
165	MEASLES VACCINE [CHEMICAL/INGREDIENT]
166	LIVE ATTENUATED MUMPS VIRUS VACCINE [EPC]
167	MUMPS VACCINE [CHEMICAL/INGREDIENT]
168	LIVE ATTENUATED RUBELLA VIRUS VACCINE [EPC]
169	RUBELLA VACCINE [CHEMICAL/INGREDIENT]
170	LIVE ATTENUATED VARICELLA ZOSTER VIRUS VACCINE [EPC]
171	CHICKENPOX VACCINE [CHEMICAL/INGREDIENT]
172	LIVE ATTENUATED HERPES ZOSTER VIRUS VACCINE [EPC]
173	HERPES ZOSTER VACCINE [CHEMICAL/INGREDIENT]
174	INACTIVATED HAEMOPHILUS INFLUENZAE B VACCINE [EPC]
175	HAEMOPHILUS VACCINES [CHEMICAL/INGREDIENT]
176	ADRENERGIC ALPHA-ANTAGONISTS [MOA]
177	ADRENERGIC BETA1-ANTAGONISTS [MOA]
178	ADRENERGIC BETA2-ANTAGONISTS [MOA]
179	ALPHA-ADRENERGIC BLOCKER [EPC]
180	DECREASED RENAL K+ EXCRETION [PE]
181	POTASSIUM-SPARING DIURETIC [EPC]
182	TOPOISOMERASE INHIBITOR [EPC]
183	TOPOISOMERASE INHIBITORS [MOA]
184	ANTI-COAGULANT [EPC]
185	DIRECT THROMBIN INHIBITOR [EPC]
186	THROMBIN INHIBITORS [MOA]
187	INCREASED MEGAKARYOCYTE MATURATION [PE]
188	INCREASED PLATELET PRODUCTION [PE]
189	THROMBOPOIESIS STIMULATING AGENT [EPC]
190	THROMBOPOIETIN RECEPTOR AGONISTS [MOA]
191	THROMBOPOIETIN RECEPTOR INTERACTIONS [MOA]
192	DOPAMINE AGONISTS [MOA]
193	NONERGOT DOPAMINE AGONIST [EPC]
194	PLEUROMUTILIN [CHEMICAL/INGREDIENT]
195	PLEUROMUTILIN ANTIBACTERIAL [EPC]
196	VINCA ALKALOID [EPC]
197	VINCA ALKALOIDS [CHEMICAL/INGREDIENT]
198	PROTON PUMP INHIBITOR [EPC]
199	PROTON PUMP INHIBITORS [MOA]
200	DECREASED IMMUNOLOGIC ACTIVITY [PE]
201	MTOR INHIBITOR IMMUNOSUPPRESSANT [EPC]
202	MTOR INHIBITORS [MOA]
203	ESTROGEN [EPC]
204	ESTROGEN RECEPTOR AGONISTS [MOA]
205	ESTROGENS
206	CONJUGATED (USP) [CHEMICAL/INGREDIENT]
207	ANTIMYCOBACTERIAL [EPC]
208	CYTOCHROME P450 1A2 INHIBITORS [MOA]
209	CYTOCHROME P450 2C9 INHIBITORS [MOA]
210	TETRACYCLINE-CLASS ANTIBACTERIAL [EPC]
211	TETRACYCLINES [CHEMICAL/INGREDIENT]
212	APPETITE SUPPRESSION [PE]
213	INCREASED SYMPATHETIC ACTIVITY [PE]
214	SYMPATHOMIMETIC AMINE ANORECTIC [EPC]
215	PROGESTERONE CONGENERS [CHEMICAL/INGREDIENT]
216	PROGESTIN [EPC]
217	DECREASED SEBACEOUS GLAND ACTIVITY [PE]
218	LINCOSAMIDE ANTIBACTERIAL [EPC]
219	LINCOSAMIDES [CHEMICAL/INGREDIENT]
220	DECREASED CELL WALL SYNTHESIS &AMP; REPAIR [PE]
221	BILE ACID SEQUESTRANT [EPC]
222	BILE-ACID BINDING ACTIVITY [MOA]
223	ESTRADIOL CONGENERS [CHEMICAL/INGREDIENT]
224	SULFONYLUREA [EPC]
225	SULFONYLUREA COMPOUNDS [CHEMICAL/INGREDIENT]
226	GENITOURINARY ARTERIAL VASODILATION [PE]
227	PROSTAGLANDIN E1 AGONIST [EPC]
228	VENOUS VASODILATION [PE]
229	CHOLINERGIC MUSCARINIC ANTAGONIST [EPC]
230	CHOLINERGIC MUSCARINIC ANTAGONISTS [MOA]
231	ALPHA GLUCOSIDASE INHIBITORS [MOA]
232	ALPHA-GLUCOSIDASE INHIBITOR [EPC]
233	ANTHRACYCLINE TOPOISOMERASE INHIBITOR [EPC]
234	ANTHRACYCLINES [CHEMICAL/INGREDIENT]
235	OXAZOLIDINONE ANTIBACTERIAL [EPC]
236	OXAZOLIDINONES [CHEMICAL/INGREDIENT]
237	CHOLINERGIC NICOTINIC AGONIST [EPC]
238	NICOTINE [CHEMICAL/INGREDIENT]
239	IMMUNOGLOBULIN G [EPC]
240	LYMPHOCYTE FUNCTION ALTERATION [PE]
241	INCREASED T LYMPHOCYTE DESTRUCTION [PE]
242	ANTIBODY-SURFACE PROTEIN INTERACTIONS [MOA]
243	IMMUNOGLOBULINS [CHEMICAL/INGREDIENT]
244	AROMATASE INHIBITOR [EPC]
245	AROMATASE INHIBITORS [MOA]
246	AMINOSALICYLATE [EPC]
247	AMINOSALICYLIC ACIDS [CHEMICAL/INGREDIENT]
248	ALKYLATING ACTIVITY [MOA]
249	ALKYLATING DRUG [EPC]
250	ESTRADIOL [CHEMICAL/INGREDIENT]
251	NITROGEN MUSTARD COMPOUNDS [CHEMICAL/INGREDIENT]
252	ANTIFIBRINOLYTIC AGENT [EPC]
253	DECREASED FIBRINOLYSIS [PE]
254	RIFAMYCIN ANTIMYCOBACTERIAL [EPC]
255	RIFAMYCINS [CHEMICAL/INGREDIENT]
256	CYTOPROTECTIVE AGENT [EPC]
257	RADIOGRAPHIC CONTRAST AGENT [EPC]
258	X-RAY CONTRAST ACTIVITY [MOA]
259	GADOLINIUM-BASED CONTRAST AGENT [EPC]
260	MAGNETIC RESONANCE CONTRAST ACTIVITY [MOA]
261	RADIOPHARMACEUTICAL ACTIVITY [MOA]
262	RADIOACTIVE THERAPEUTIC AGENT [EPC]
263	RETINOID [EPC]
264	RETINOIDS [CHEMICAL/INGREDIENT]
265	AMINOGLYCOSIDE ANTIBACTERIAL [EPC]
266	AMINOGLYCOSIDES [CHEMICAL/INGREDIENT]
267	SULFONAMIDE ANTIBACTERIAL [EPC]
268	SULFONAMIDES [CHEMICAL/INGREDIENT]
269	ACETYLCHOLINE RELEASE INHIBITOR [EPC]
270	ACETYLCHOLINE RELEASE INHIBITORS [MOA]
271	QUINOLONE ANTIMICROBIAL [EPC]
272	QUINOLONES [CHEMICAL/INGREDIENT]
273	SULFONE [EPC]
274	SULFONES [CHEMICAL/INGREDIENT]
275	ANTIPROTOZOAL [EPC]
276	DECARBOXYLASE INHIBITOR [EPC]
277	DECARBOXYLASE INHIBITORS [MOA]
278	POLYMYXIN-CLASS ANTIBACTERIAL [EPC]
279	POLYMYXINS [CHEMICAL/INGREDIENT]
280	DIHYDROFOLATE REDUCTASE INHIBITOR ANTIBACTERIAL [EPC]
281	DIHYDROFOLATE REDUCTASE INHIBITORS [MOA]
282	CYTOCHROME P450 2C8 INHIBITORS [MOA]
283	ORGANIC CATION TRANSPORTER 2 INHIBITORS [MOA]
284	DECREASED PROTEIN SYNTHESIS [PE]
285	DECREASED HISTAMINE RELEASE [PE]
286	MAST CELL STABILIZER [EPC]
287	CALCINEURIN INHIBITOR IMMUNOSUPPRESSANT [EPC]
288	CALCINEURIN INHIBITORS [MOA]
289	ADRENERGIC ALPHA-AGONISTS [MOA]
290	ALPHA-ADRENERGIC AGONIST [EPC]
291	ADRENERGIC AGONISTS [MOA]
292	ADRENERGIC RECEPTOR AGONIST [EPC]
293	HISTAMINE H1 RECEPTOR ANTAGONISTS [MOA]
294	HISTAMINE-1 RECEPTOR INHIBITOR [EPC]
295	FULL OPIOID AGONISTS [MOA]
296	OPIOID AGONIST [EPC]
297	ERGOCALCIFEROLS [CHEMICAL/INGREDIENT]
298	PROVITAMIN D2 COMPOUND [EPC]
299	PLATINUM-BASED DRUG [EPC]
300	PLATINUM-CONTAINING COMPOUNDS [CHEMICAL/INGREDIENT]
301	ANTISEPTIC [EPC]
302	ANTIRHEUMATIC AGENT [EPC]
303	ANTIMALARIAL [EPC]
304	IRON [CHEMICAL/INGREDIENT]
305	PARENTERAL IRON REPLACEMENT [EPC]
306	PHOSPHATE BINDER [EPC]
307	PHOSPHATE CHELATING ACTIVITY [MOA]
308	GAMMA-AMINOBUTYRIC ACID-ERGIC AGONIST [EPC]
309	GABA A AGONISTS [MOA]
310	PYRIDINES [CHEMICAL/INGREDIENT]
311	CENTRAL NERVOUS SYSTEM DEPRESSION [PE]
312	HISTAMINE-1 RECEPTOR ANTAGONIST [EPC]
313	AMINOKETONE [EPC]
314	DOPAMINE UPTAKE INHIBITORS [MOA]
315	INCREASED DOPAMINE ACTIVITY [PE]
316	INCREASED NOREPINEPHRINE ACTIVITY [PE]
317	ADRENERGIC BETA-AGONISTS [MOA]
318	BETA-ADRENERGIC AGONIST [EPC]
319	CATECHOLAMINE [EPC]
320	CATECHOLAMINES [CHEMICAL/INGREDIENT]
321	GRANULOCYTE COLONY-STIMULATING FACTOR [CHEMICAL/INGREDIENT]
322	GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR [CHEMICAL/INGREDIENT]
323	INCREASED MYELOID CELL PRODUCTION [PE]
324	LEUKOCYTE GROWTH FACTOR [EPC]
325	HEMATOPOIETIC STEM CELL MOBILIZER [EPC]
326	INCREASED HEMATOPOIETIC STEM CELL MOBILIZATION [PE]
327	ANTIDIARRHEAL [EPC]
328	ANTICHOLINERGIC [EPC]
329	CHOLINERGIC ANTAGONISTS [MOA]
330	GONADOTROPIN RELEASING HORMONE RECEPTOR AGONIST [EPC]
331	GONADOTROPIN RELEASING HORMONE RECEPTOR AGONISTS [MOA]
332	ALDOSTERONE ANTAGONIST [EPC]
333	ALDOSTERONE ANTAGONISTS [MOA]
334	DECREASED PROSTAGLANDIN PRODUCTION [PE]
335	PROSTAGLANDIN E1 ANALOG [EPC]
336	PROSTAGLANDINS E
337	SYNTHETIC [CHEMICAL/INGREDIENT]
338	NITROIMIDAZOLE ANTIMICROBIAL [EPC]
339	NITROIMIDAZOLES [CHEMICAL/INGREDIENT]
340	CALCIUM CHANNEL ANTAGONISTS [MOA]
341	CALCIUM CHANNEL BLOCKER [EPC]
342	RNA SYNTHETASE INHIBITOR ANTIBACTERIAL [EPC]
343	RNA SYNTHETASE INHIBITORS [MOA]
344	PENICILLIN-CLASS ANTIBACTERIAL [EPC]
345	PENICILLINS [CHEMICAL/INGREDIENT]
346	BETA LACTAMASE INHIBITOR [EPC]
347	BETA LACTAMASE INHIBITORS [MOA]
348	PROGESTERONE [CHEMICAL/INGREDIENT]
349	PROGESTERONE [EPC]
350	ANTI-EPILEPTIC AGENT [EPC]
351	DECREASED CENTRAL NERVOUS SYSTEM DISORGANIZED ELECTRICAL ACTIVITY [PE]
352	CANNABINOID [EPC]
353	CANNABINOIDS [CHEMICAL/INGREDIENT]
354	CENTRALLY-MEDIATED MUSCLE RELAXATION [PE]
355	MUSCLE RELAXANT [EPC]
356	INCREASED DIURESIS AT LOOP OF HENLE [PE]
357	LOOP DIURETIC [EPC]
358	OSMOTIC ACTIVITY [MOA]
359	OSMOTIC LAXATIVE [EPC]
360	STIMULATION LARGE INTESTINE FLUID/ELECTROLYTE SECRETION [PE]
361	POTASSIUM COMPOUNDS [CHEMICAL/INGREDIENT]
362	POTASSIUM SALT [EPC]
363	VITAMIN B 12 [CHEMICAL/INGREDIENT]
364	VITAMIN B12 [EPC]
365	ANTIEMETIC [EPC]
366	EMESIS SUPPRESSION [PE]
367	AZOLE ANTIFUNGAL [EPC]
368	AZOLES [CHEMICAL/INGREDIENT]
369	CYTOCHROME P450 2C19 INHIBITORS [MOA]
370	ANTIHISTAMINE [EPC]
371	HISTAMINE RECEPTOR ANTAGONISTS [MOA]
372	TYPICAL ANTIPSYCHOTIC [EPC]
373	DECREASED GNRH SECRETION [PE]
374	GONADOTROPIN RELEASING HORMONE ANTAGONIST [EPC]
375	GONADOTROPIN RELEASING HORMONE RECEPTOR ANTAGONISTS [MOA]
376	GONADOTROPIN [EPC]
377	GONADOTROPINS [CHEMICAL/INGREDIENT]
378	NEUROMUSCULAR NONDEPOLARIZING BLOCKADE [PE]
379	NONDEPOLARIZING NEUROMUSCULAR BLOCKER [EPC]
380	LIVE ATTENUATED BACILLUS CALMETTE-GUERIN VACCINE [EPC]
381	BCG VACCINE [CHEMICAL/INGREDIENT]
382	LIVE ATTENUATED BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY [EPC]
383	INCREASED MACROPHAGE PROLIFERATION [PE]
384	INCREASED IMMUNOLOGICALLY ACTIVE MOLECULE ACTIVITY [PE]
385	FACTOR VIII ACTIVATOR [EPC]
386	INCREASED COAGULATION FACTOR VIII ACTIVITY [PE]
387	INCREASED COAGULATION FACTOR VIII CONCENTRATION [PE]
388	VASOPRESSIN ANALOG [EPC]
389	VASOPRESSINS [CHEMICAL/INGREDIENT]
390	HUMAN IMMUNOGLOBULIN G [EPC]
391	PASSIVELY ACQUIRED IMMUNITY [PE]
392	ANTIGEN NEUTRALIZATION [MOA]
393	HUMAN SERUM ALBUMIN [EPC]
394	INCREASED INTRAVASCULAR VOLUME [PE]
395	INCREASED ONCOTIC PRESSURE [PE]
396	SERUM ALBUMIN [CHEMICAL/INGREDIENT]
397	CHOLECALCIFEROL [CHEMICAL/INGREDIENT]
398	VITAMIN D3 ANALOG [EPC]
399	MOOD STABILIZER [EPC]
400	PHOSPHODIESTERASE 3 INHIBITOR [EPC]
401	PHOSPHODIESTERASE 3 INHIBITORS [MOA]
402	MACROLIDE ANTIMICROBIAL [EPC]
403	MACROLIDES [CHEMICAL/INGREDIENT]
404	CHOLINERGIC AGONISTS [MOA]
405	CHOLINERGIC MUSCARINIC AGONISTS [MOA]
406	CHOLINERGIC RECEPTOR AGONIST [EPC]
407	CARDIAC GLYCOSIDE [EPC]
408	CARDIAC GLYCOSIDES [CHEMICAL/INGREDIENT]
409	SEROTONIN 3 RECEPTOR ANTAGONISTS [MOA]
410	SEROTONIN-3 RECEPTOR ANTAGONIST [EPC]
411	GAMMA-AMINOBUTYRIC ACID A RECEPTOR AGONIST [EPC]
412	BLOOD COAGULATION FACTOR [EPC]
413	INCREASED COAGULATION FACTOR ACTIVITY [PE]
414	CALCIUM [CHEMICAL/INGREDIENT]
415	CATIONS
416	DIVALENT [CHEMICAL/INGREDIENT]
417	DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER [EPC]
418	DIHYDROPYRIDINES [CHEMICAL/INGREDIENT]
419	HERPES SIMPLEX VIRUS NUCLEOSIDE ANALOG DNA POLYMERASE INHIBITOR [EPC]
420	HERPES ZOSTER VIRUS NUCLEOSIDE ANALOG DNA POLYMERASE INHIBITOR [EPC]
421	HERPESVIRUS NUCLEOSIDE ANALOG DNA POLYMERASE INHIBITOR [EPC]
422	CHOLINESTERASE INHIBITOR [EPC]
423	CHOLINESTERASE INHIBITORS [MOA]
424	PARTIAL OPIOID AGONIST [EPC]
425	PARTIAL OPIOID AGONISTS [MOA]
426	OPIOID ANTAGONIST [EPC]
427	OPIOID ANTAGONISTS [MOA]
428	TRICYCLIC ANTIDEPRESSANT [EPC]
429	VITAMIN D2 ANALOG [EPC]
430	ACETYL ALDEHYDE DEHYDROGENASE INHIBITORS [MOA]
431	ALDEHYDE DEHYDROGENASE INHIBITOR [EPC]
432	PLATELET AGGREGATION INHIBITOR [EPC]
433	HUMAN IMMUNODEFICIENCY VIRUS 1 NON-NUCLEOSIDE ANALOG REVERSE TRANSCRIPTASE INHIBITOR [EPC]
434	NON-NUCLEOSIDE ANALOG [CHEMICAL/INGREDIENT]
435	NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS [MOA]
436	CYTOCHROME P450 3A INDUCERS [MOA]
437	CYTOCHROME P450 2B6 INDUCERS [MOA]
438	ANTIDOTE [EPC]
439	ANTIDOTE FOR ACETAMINOPHEN OVERDOSE [EPC]
440	DECREASED RESPIRATORY SECRETION VISCOSITY [PE]
441	INCREASED GLUTATHIONE CONCENTRATION [PE]
442	MUCOLYTIC [EPC]
443	REDUCTION ACTIVITY [MOA]
444	COMPETITIVE OPIOID ANTAGONISTS [MOA]
445	OPIOID AGONIST/ANTAGONIST [EPC]
446	ACIDIFYING ACTIVITY [MOA]
447	AMIDE LOCAL ANESTHETIC [EPC]
448	AMIDES [CHEMICAL/INGREDIENT]
449	LOCAL ANESTHESIA [PE]
450	PURINE ANTIMETABOLITE [EPC]
451	PURINES [CHEMICAL/INGREDIENT]
452	FOLATE ANALOG [EPC]
453	FOLIC ACID [CHEMICAL/INGREDIENT]
454	VITAMIN K ANTAGONIST [EPC]
455	VITAMIN K INHIBITORS [MOA]
456	HUMAN PLATELET-DERIVED GROWTH FACTOR [EPC]
457	PLATELET-DERIVED GROWTH FACTOR [CHEMICAL/INGREDIENT]
458	COLLAGENASES [CHEMICAL/INGREDIENT]
459	COLLAGEN-SPECIFIC ENZYME [EPC]
460	DIAGNOSTIC DYE [EPC]
461	DYES [MOA]
462	ALPHA-1 ADRENERGIC AGONIST [EPC]
463	ADRENERGIC ALPHA1-AGONISTS [MOA]
464	POLYENE ANTIMICROBIAL [EPC]
465	POLYENES [CHEMICAL/INGREDIENT]
466	ESTER LOCAL ANESTHETIC [EPC]
467	ESTERS [CHEMICAL/INGREDIENT]
468	CALCULI DISSOLUTION AGENT [EPC]
469	MAGNESIUM ION EXCHANGE ACTIVITY [MOA]
470	RIFAMYCIN ANTIBACTERIAL [EPC]
471	GENERAL ANESTHESIA [PE]
472	GENERAL ANESTHETIC [EPC]
473	HEPARIN [CHEMICAL/INGREDIENT]
474	UNFRACTIONATED HEPARIN [EPC]
475	MICROTUBULE INHIBITION [PE]
476	MICROTUBULE INHIBITOR [EPC]
477	BENZODIAZEPINE ANTAGONIST [EPC]
478	HYDROLYTIC LYSOSOMAL GLUCOCEREBROSIDE-SPECIFIC ENZYME [EPC]
479	GLUCOSYLCERAMIDASE [CHEMICAL/INGREDIENT]
480	HISTAMINE H2 RECEPTOR ANTAGONISTS [MOA]
481	HISTAMINE-2 RECEPTOR ANTAGONIST [EPC]
482	DECREASED TRACHEOBRONCHIAL STRETCH RECEPTOR ACTIVITY [PE]
483	NON-NARCOTIC ANTITUSSIVE [EPC]
484	RECEPTOR TYROSINE KINASE INHIBITORS [MOA]
485	HEPARIN
486	LOW-MOLECULAR-WEIGHT [CHEMICAL/INGREDIENT]
487	LOW MOLECULAR WEIGHT HEPARIN [EPC]
488	PARTIAL CHOLINERGIC NICOTINIC AGONIST [EPC]
489	PARTIAL CHOLINERGIC NICOTINIC AGONISTS [MOA]
490	CCR5 CO-RECEPTOR ANTAGONIST [EPC]
491	CHEMOKINE CO-RECEPTOR 5 ANTAGONISTS [MOA]
492	JANUS KINASE INHIBITOR [EPC]
493	JANUS KINASE INHIBITORS [MOA]
494	GLYCOPEPTIDE ANTIBACTERIAL [EPC]
495	GLYCOPEPTIDES [CHEMICAL/INGREDIENT]
496	CYTOCHROME P450 1A2 INDUCERS [MOA]
497	CYTOCHROME P450 2C8 INDUCERS [MOA]
498	CYTOCHROME P450 2C19 INDUCERS [MOA]
499	CYTOCHROME P450 2D6 INDUCERS [MOA]
500	CYTOCHROME P450 2B6 INHIBITORS [MOA]
501	ORGANIC CATION TRANSPORTER 1 INHIBITORS [MOA]
502	MONOAMINE OXIDASE INHIBITOR [EPC]
503	MONOAMINE OXIDASE INHIBITORS [MOA]
504	NITRATE VASODILATOR [EPC]
505	NITRATES [CHEMICAL/INGREDIENT]
506	VASODILATION [PE]
507	PEROXISOME PROLIFERATOR RECEPTOR ALPHA AGONIST [EPC]
508	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA AGONISTS [MOA]
509	PPAR ALPHA [CHEMICAL/INGREDIENT]
510	ALVEOLAR SURFACE TENSION REDUCTION [PE]
511	SURFACTANT [EPC]
512	SURFACTANT ACTIVITY [MOA]
513	OPIOID AGONISTS [MOA]
514	NICOTINIC ACID [EPC]
515	NICOTINIC ACIDS [CHEMICAL/INGREDIENT]
516	L-THYROXINE [EPC]
517	THYROXINE [CHEMICAL/INGREDIENT]
518	TUMOR NECROSIS FACTOR BLOCKER [EPC]
519	TUMOR NECROSIS FACTOR RECEPTOR BLOCKING ACTIVITY [MOA]
520	MACROLIDE [EPC]
521	BENZOTHIAZOLE [EPC]
522	BENZOTHIAZOLES [CHEMICAL/INGREDIENT]
523	AMMONIUM ION BINDING ACTIVITY [MOA]
524	NITROGEN BINDING AGENT [EPC]
525	CALCITONIN [CHEMICAL/INGREDIENT]
526	CALCITONIN [EPC]
527	ALLYLAMINE [CHEMICAL/INGREDIENT]
528	ALLYLAMINE ANTIFUNGAL [EPC]
529	SOMATOSTATIN ANALOG [EPC]
530	SOMATOSTATIN RECEPTOR AGONISTS [MOA]
531	CATECHOL O-METHYLTRANSFERASE INHIBITORS [MOA]
532	CATECHOL-O-METHYLTRANSFERASE INHIBITOR [EPC]
533	INTERLEUKIN 2 RECEPTOR ANTAGONISTS [MOA]
534	INTERLEUKIN 2 RECEPTOR-DIRECTED ANTIBODY INTERACTIONS [MOA]
535	INTERLEUKIN-2 RECEPTOR BLOCKING ANTIBODY [EPC]
536	IRON CHELATING ACTIVITY [MOA]
537	IRON CHELATOR [EPC]
538	GLINIDE [EPC]
539	POTASSIUM CHANNEL ANTAGONISTS [MOA]
540	DECREASED BLOOD PRESSURE [PE]
541	CENTRAL NERVOUS SYSTEM STIMULANT [EPC]
542	CENTRAL NERVOUS SYSTEM STIMULATION [PE]
543	CYTOCHROME P450 3A4 INDUCERS [MOA]
544	RENIN INHIBITOR [EPC]
545	RENIN INHIBITORS [MOA]
546	INCREASED LYMPHOCYTE ACTIVATION [PE]
547	INCREASED LYMPHOCYTE CELL PRODUCTION [PE]
548	INTERLEUKIN-2 [CHEMICAL/INGREDIENT]
549	LYMPHOCYTE GROWTH FACTOR [EPC]
550	SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATORS [MOA]
551	SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR [EPC]
552	HCV NS3/4A PROTEASE INHIBITORS [MOA]
553	HEPATITIS C VIRUS NS3/4A PROTEASE INHIBITOR [EPC]
554	CYTOCHROME P450 3A5 INHIBITORS [MOA]
555	ACETYLCHOLINE RELEASING AGENT [EPC]
556	INCREASED ACETYLCHOLINE ACTIVITY [PE]
557	ADRENERGIC BETA2-AGONISTS [MOA]
558	BETA2-ADRENERGIC AGONIST [EPC]
559	INTERFERON ALFA-2B [CHEMICAL/INGREDIENT]
560	INTERFERON-ALPHA [CHEMICAL/INGREDIENT]
561	ANDROGEN RECEPTOR ANTAGONISTS [MOA]
562	ANDROGEN RECEPTOR INHIBITOR [EPC]
563	KETOLIDE ANTIBACTERIAL [EPC]
564	KETOLIDES [CHEMICAL/INGREDIENT]
565	LEAD CHELATING ACTIVITY [MOA]
566	LEAD CHELATOR [EPC]
567	DECREASED COAGULATION FACTOR ACTIVITY [PE]
568	CALCIUM CHELATING ACTIVITY [MOA]
569	DOPAMINE D2 ANTAGONISTS [MOA]
570	DOPAMINE-2 RECEPTOR ANTAGONIST [EPC]
571	SULFONAMIDE ANTIMICROBIAL [EPC]
572	POLYENE ANTIFUNGAL [EPC]
573	CARDIAC RHYTHM ALTERATION [PE]
574	PEROXISOME PROLIFERATOR RECEPTOR GAMMA AGONIST [EPC]
575	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ACTIVITY [MOA]
576	PPAR GAMMA [CHEMICAL/INGREDIENT]
577	THIAZOLIDINEDIONE [EPC]
578	THIAZOLIDINEDIONES [CHEMICAL/INGREDIENT]
579	NITROFURAN ANTIBACTERIAL [EPC]
580	NITROFURANS [CHEMICAL/INGREDIENT]
581	ALUMINUM COMPLEX [EPC]
582	ORGANOMETALLIC COMPOUNDS [CHEMICAL/INGREDIENT]
583	ADRENERGIC ALPHA2-AGONISTS [MOA]
584	CENTRAL ALPHA-2 ADRENERGIC AGONIST [EPC]
585	TETRACYCLINE-CLASS DRUG [EPC]
586	BLOOD VISCOSITY REDUCER [EPC]
587	HEMATOLOGIC ACTIVITY ALTERATION [PE]
588	FATTY ACIDS
589	OMEGA-3 [CHEMICAL/INGREDIENT]
590	OMEGA-3 FATTY ACID [EPC]
591	ERGOLINES [CHEMICAL/INGREDIENT]
592	ERGOT DERIVATIVE [EPC]
593	INCREASED CYTOKINE ACTIVITY [PE]
594	INCREASED CYTOKINE PRODUCTION [PE]
595	INTERFERON INDUCERS [MOA]
596	DECREASED MITOSIS [PE]
597	TUBULIN INHIBITING AGENT [EPC]
598	PHENOTHIAZINE [EPC]
599	PHENOTHIAZINES [CHEMICAL/INGREDIENT]
600	BARBITURATE [EPC]
601	BARBITURATES [CHEMICAL/INGREDIENT]
602	VITAMIN D ANALOG [EPC]
603	BILE ACID [EPC]
604	BILE ACIDS AND SALTS [CHEMICAL/INGREDIENT]
605	INFLUENZA A M2 PROTEIN INHIBITOR [EPC]
606	M2 PROTEIN INHIBITORS [MOA]
607	TETRACYCLINE-CLASS ANTIMICROBIAL [EPC]
608	DECREASED STRIATED MUSCLE CONTRACTION [PE]
609	DECREASED STRIATED MUSCLE TONE [PE]
610	SKELETAL MUSCLE RELAXANT [EPC]
611	CHOLINERGIC MUSCARINIC AGONIST [EPC]
612	DECREASED CELL WALL INTEGRITY [PE]
613	METHYLXANTHINE [EPC]
614	XANTHINES [CHEMICAL/INGREDIENT]
615	THYROID HORMONE SYNTHESIS INHIBITOR [EPC]
616	THYROID HORMONE SYNTHESIS INHIBITORS [MOA]
617	ERGOTAMINE DERIVATIVE [EPC]
618	ERGOTAMINES [CHEMICAL/INGREDIENT]
619	P-GLYCOPROTEIN INTERACTIONS [MOA]
620	INCREASED UTERINE SMOOTH MUSCLE CONTRACTION OR TONE [PE]
621	OXYTOCIC [EPC]
622	OXYTOCIN [CHEMICAL/INGREDIENT]
623	DECREASED DNA REPLICATION [PE]
624	DECREASED RNA REPLICATION [PE]
625	PROTEIN SYNTHESIS INHIBITORS [MOA]
626	GLP-1 RECEPTOR AGONIST [EPC]
627	GLUCAGON-LIKE PEPTIDE 1 [CHEMICAL/INGREDIENT]
628	GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AGONISTS [MOA]
629	RECOMBINANT HUMAN GROWTH HORMONE [EPC]
630	RECOMBINANT HUMAN GROWTH HORMONES [CHEMICAL/INGREDIENT]
631	GABA B AGONISTS [MOA]
632	DECREASED PLATELET PRODUCTION [PE]
633	PLATELET-REDUCING AGENT [EPC]
634	PROSTACYCLINE VASODILATOR [EPC]
635	PROSTAGLANDINS I [CHEMICAL/INGREDIENT]
636	NEURAMINIDASE INHIBITOR [EPC]
637	NEURAMINIDASE INHIBITORS [MOA]
638	POTASSIUM CHANNEL OPENERS [MOA]
639	POTASSIUM CHANNEL OPENER [EPC]
640	CD20-DIRECTED CYTOLYTIC ANTIBODY [EPC]
641	CD20-DIRECTED ANTIBODY INTERACTIONS [MOA]
642	ORGANIC ANION TRANSPORTER 1 INHIBITORS [MOA]
643	ORGANIC ANION TRANSPORTER 3 INHIBITORS [MOA]
644	UREASE INHIBITOR [EPC]
645	UREASE INHIBITORS [MOA]
646	CALCIUM [EPC]
647	CYSTINE DISULFIDE REDUCTION [MOA]
648	N-SUBSTITUTED GLYCINES [CHEMICAL/INGREDIENT]
649	REDUCING AND COMPLEXING THIOL [EPC]
650	THIAZIDE-LIKE DIURETIC [EPC]
651	L-TRIIODOTHYRONINE [EPC]
652	TRIIODOTHYRONINE [CHEMICAL/INGREDIENT]
653	DIHYDROFOLATE REDUCTASE INHIBITOR ANTIMALARIAL [EPC]
654	INCREASED PROTHROMBIN ACTIVITY [PE]
655	REVERSED ANTICOAGULATION ACTIVITY [PE]
656	VITAMIN K [CHEMICAL/INGREDIENT]
657	VITAMIN K [EPC]
658	WARFARIN REVERSAL AGENT [EPC]
659	CATECHOLAMINE-DEPLETING SYMPATHOLYTIC [EPC]
660	DECREASED SYMPATHETIC ACTIVITY [PE]
661	PHENYLALANINE HYDROXYLASE ACTIVATORS [MOA]
662	PHOTOABSORPTION [MOA]
663	PHOTOACTIVATED RADICAL GENERATOR [EPC]
664	PHOTOSENSITIZING ACTIVITY [PE]
665	PSORALEN [EPC]
666	PSORALENS [CHEMICAL/INGREDIENT]
667	MONOAMINE OXIDASE TYPE B INHIBITOR [EPC]
668	MONOAMINE OXIDASE-B INHIBITORS [MOA]
669	METAL CHELATING ACTIVITY [MOA]
670	METAL CHELATOR [EPC]
671	NUCLEOSIDE ANALOG ANTIFUNGAL [EPC]
672	DECREASED PARASYMPATHETIC ACETYLCHOLINE ACTIVITY [PE]
673	GI MOTILITY ALTERATION [PE]
674	DIGESTIVE/GI SYSTEM ACTIVITY ALTERATION [PE]
675	PHOTOENHANCER [EPC]
676	NON-STANDARDIZED PLANT ALLERGENIC EXTRACT [EPC]
677	NON-STANDARDIZED FOOD ALLERGENIC EXTRACT [EPC]
678	DIETARY PROTEINS [CHEMICAL/INGREDIENT]
679	PLANT PROTEINS [CHEMICAL/INGREDIENT]
680	FOOD ADDITIVES [CHEMICAL/INGREDIENT]
681	NON-STANDARDIZED CHEMICAL ALLERGEN [EPC]
682	GLYCEROL [CHEMICAL/INGREDIENT]
683	AMINO ACID [EPC]
684	AMINO ACIDS [CHEMICAL/INGREDIENT]
685	PLASMA VOLUME EXPANDER [EPC]
686	STARCH [CHEMICAL/INGREDIENT]
687	OSMOTIC DIURETIC [EPC]
688	NON-STANDARDIZED HOUSE DUST ALLERGENIC EXTRACT [EPC]
689	HOUSE DUST [CHEMICAL/INGREDIENT]
690	NON-STANDARDIZED POLLEN ALLERGENIC EXTRACT [EPC]
691	STANDARDIZED ANIMAL SKIN ALLERGENIC EXTRACT [EPC]
692	FUR [CHEMICAL/INGREDIENT]
693	STANDARDIZED INSECT ALLERGENIC EXTRACT [EPC]
694	ANTIGENS
695	DERMATOPHAGOIDES [CHEMICAL/INGREDIENT]
696	INSECT PROTEINS [CHEMICAL/INGREDIENT]
697	NON-STANDARDIZED ANIMAL SKIN ALLERGENIC EXTRACT [EPC]
698	CELLS
699	EPIDERMAL [CHEMICAL/INGREDIENT]
700	NON-STANDARDIZED PLANT FIBER ALLERGENIC EXTRACT [EPC]
701	SEED STORAGE PROTEINS [CHEMICAL/INGREDIENT]
702	MEAT PROTEINS [CHEMICAL/INGREDIENT]
703	NON-STANDARDIZED INSECT ALLERGENIC EXTRACT [EPC]
704	NON-STANDARDIZED FUNGAL ALLERGENIC EXTRACT [EPC]
705	FUNGAL PROTEINS [CHEMICAL/INGREDIENT]
706	STANDARDIZED ANIMAL HAIR ALLERGENIC EXTRACT [EPC]
707	DANDER [CHEMICAL/INGREDIENT]
708	SALIVARY PROTEINS AND PEPTIDES [CHEMICAL/INGREDIENT]
709	NUT PROTEINS [CHEMICAL/INGREDIENT]
710	FRUIT PROTEINS [CHEMICAL/INGREDIENT]
711	VEGETABLE PROTEINS [CHEMICAL/INGREDIENT]
712	GRAIN PROTEINS [CHEMICAL/INGREDIENT]
713	CASEINS [CHEMICAL/INGREDIENT]
714	POULTRY PROTEINS [CHEMICAL/INGREDIENT]
715	SHELLFISH PROTEINS [CHEMICAL/INGREDIENT]
716	FISH PROTEINS
717	DIETARY [CHEMICAL/INGREDIENT]
718	EGG PROTEINS
719	MILK PROTEINS [CHEMICAL/INGREDIENT]
720	NON-STANDARDIZED INSECT VENOM ALLERGENIC EXTRACT [EPC]
721	ANT VENOMS [CHEMICAL/INGREDIENT]
722	CHOLECYSTOKININ [CHEMICAL/INGREDIENT]
723	CHOLECYSTOKININ ANALOG [EPC]
724	PARAMAGNETIC CONTRAST AGENT [EPC]
725	DIGOXIN BINDING ACTIVITY [MOA]
726	DEPIGMENTING ACTIVITY [PE]
727	MELANIN SYNTHESIS INHIBITOR [EPC]
728	MELANIN SYNTHESIS INHIBITORS [MOA]
729	ESTROGEN RECEPTOR ANTAGONIST [EPC]
730	ESTROGEN RECEPTOR ANTAGONISTS [MOA]
731	AMYLIN AGONISTS [MOA]
732	AMYLIN ANALOG [EPC]
733	IRRIGATION [MOA]
734	XANTHINE OXIDASE INHIBITOR [EPC]
735	XANTHINE OXIDASE INHIBITORS [MOA]
736	SYMPATHOMIMETIC-LIKE AGENT [EPC]
737	BENZYLAMINE ANTIFUNGAL [EPC]
738	BENZYLAMINES [CHEMICAL/INGREDIENT]
739	AMPHETAMINE ANORECTIC [EPC]
740	AMPHETAMINES [CHEMICAL/INGREDIENT]
741	CYSTINE DEPLETING AGENT [EPC]
742	STANDARDIZED CHEMICAL ALLERGEN [EPC]
743	CONTRAST AGENT FOR ULTRASOUND IMAGING [EPC]
744	ULTRASOUND CONTRAST ACTIVITY [MOA]
745	LIPOPEPTIDE ANTIBACTERIAL [EPC]
746	PARTIAL OPIOID AGONIST/ANTAGONIST [EPC]
747	ADENOSINE RECEPTOR AGONIST [EPC]
748	ADENOSINE RECEPTOR AGONISTS [MOA]
749	DOPAMINERGIC AGONIST [EPC]
750	PYROPHOSPHATE ANALOG [CHEMICAL/INGREDIENT]
751	PYROPHOSPHATE ANALOG DNA POLYMERASE INHIBITOR [EPC]
752	COPPER ABSORPTION INHIBITOR [EPC]
753	DECREASED COPPER ION ABSORPTION [PE]
754	DEPOLARIZING NEUROMUSCULAR BLOCKER [EPC]
755	NEUROMUSCULAR DEPOLARIZING BLOCKADE [PE]
756	PHOSPHODIESTERASE 4 INHIBITOR [EPC]
757	PHOSPHODIESTERASE 4 INHIBITORS [MOA]
758	GUANYLATE CYCLASE-C AGONIST [EPC]
759	GUANYLATE CYCLASE ACTIVATORS [MOA]
760	NMDA RECEPTOR ANTAGONISTS [MOA]
761	N-METHYL-D-ASPARTATE RECEPTOR ANTAGONIST [EPC]
762	BETA3-ADRENERGIC AGONIST [EPC]
763	ADRENERGIC BETA3-AGONISTS [MOA]
764	LIPID-BASED POLYENE ANTIFUNGAL [EPC]
765	PYRETHRINS [CHEMICAL/INGREDIENT]
766	PYRETHROID [EPC]
767	UNCOMPETITIVE N-METHYL-D-ASPARTATE RECEPTOR ANTAGONIST [EPC]
768	SIGMA-1 AGONIST [EPC]
769	UNCOMPETITIVE NMDA RECEPTOR ANTAGONISTS [MOA]
770	SIGMA-1 RECEPTOR AGONISTS [MOA]
771	ARTERIOLAR VASODILATION [PE]
772	ARTERIOLAR VASODILATOR [EPC]
773	CARNITINE [CHEMICAL/INGREDIENT]
774	CARNITINE ANALOG [EPC]
775	COPPER [CHEMICAL/INGREDIENT]
776	COPPER-CONTAINING INTRAUTERINE DEVICE [EPC]
777	DECREASED EMBRYONIC IMPLANTATION [PE]
778	DECREASED SPERM MOTILITY [PE]
779	INHIBIT OVUM FERTILIZATION [PE]
780	ADRENOCORTICOTROPIC HORMONE [CHEMICAL/INGREDIENT]
781	ADRENOCORTICOTROPIC HORMONE [EPC]
782	ENDOGLYCOSIDASE [EPC]
783	GLYCOSIDE HYDROLASES [CHEMICAL/INGREDIENT]
784	ENDOGENOUS ANTIGEN NEUTRALIZATION [MOA]
785	ANTIHYPOGLYCEMIC AGENT [EPC]
786	GASTROINTESTINAL MOTILITY INHIBITOR [EPC]
787	INCREASED GLUCONEOGENESIS [PE]
788	INCREASED GLYCOGENOLYSIS [PE]
789	DECREASED GI SMOOTH MUSCLE TONE [PE]
790	DECREASED GI MOTILITY [PE]
791	DECREASED GLYCOLYSIS [PE]
792	VITAMIN A [CHEMICAL/INGREDIENT]
793	VITAMIN A [EPC]
794	INCREASED MEDULLARY RESPIRATORY DRIVE [PE]
795	RESPIRATORY STIMULANT [EPC]
796	AUTONOMIC GANGLIONIC BLOCKER [EPC]
797	DECREASED AUTONOMIC GANGLIONIC ACTIVITY [PE]
798	HUMAN ALPHA-1 PROTEINASE INHIBITOR [EPC]
799	TRYPSIN INHIBITORS [MOA]
800	HUMAN BLOOD COAGULATION FACTOR [EPC]
801	INCREASED COAGULATION ACTIVITY [PE]
802	BLOOD COAGULATION FACTORS [CHEMICAL/INGREDIENT]
803	LOCAL ANESTHETIC [EPC]
804	5-LIPOXYGENASE INHIBITOR [EPC]
805	5-LIPOXYGENASE INHIBITORS [MOA]
806	DECREASED LEUKOTRIENE PRODUCTION [PE]
807	OXABOROLE ANTIFUNGAL [EPC]
808	BORON COMPOUNDS [CHEMICAL/INGREDIENT]
809	INHALATION DIAGNOSTIC AGENT [EPC]
810	HUMAN IMMUNOGLOBULIN [EPC]
811	VIRUS NEUTRALIZATION [MOA]
812	VIRUS-SPECIFIC HYPERIMMUNE GLOBULINS [CHEMICAL/INGREDIENT]
813	INACTIVATED CLOSTRIDIUM TETANI VACCINE [EPC]
814	TETANUS TOXOID [CHEMICAL/INGREDIENT]
815	INACTIVATED CORYNEBACTERIUM DIPHTHERIAE VACCINE [EPC]
816	DIPHTHERIA TOXOID [CHEMICAL/INGREDIENT]
817	CHLORIDE CHANNEL ACTIVATOR [EPC]
818	CHLORIDE CHANNEL ACTIVATORS [MOA]
819	BEE VENOMS [CHEMICAL/INGREDIENT]
820	STANDARDIZED INSECT VENOM ALLERGENIC EXTRACT [EPC]
821	N-CALCIUM CHANNEL RECEPTOR ANTAGONISTS [MOA]
822	N-TYPE CALCIUM CHANNEL ANTAGONIST [EPC]
823	MELATONIN RECEPTOR AGONIST [EPC]
824	MELATONIN RECEPTOR AGONISTS [MOA]
825	DECREASED CHOLESTEROL ABSORPTION [PE]
826	DIETARY CHOLESTEROL ABSORPTION INHIBITOR [EPC]
827	PROGESTIN-CONTAINING INTRAUTERINE DEVICE [EPC]
828	INCREASED LARGE INTESTINAL MOTILITY [PE]
829	STIMULANT LAXATIVE [EPC]
830	CATECHOLAMINE SYNTHESIS INHIBITOR [EPC]
831	CATECHOLAMINE SYNTHESIS INHIBITORS [MOA]
832	DEMULCENT [EPC]
833	DEMULCENT ACTIVITY [MOA]
834	COMPLEMENT INHIBITOR [EPC]
835	COMPLEMENT INHIBITORS [MOA]
836	AUTOLOGOUS CELLULAR IMMUNOTHERAPY [EPC]
837	CULTURED
838	AUTOLOGOUS [CHEMICAL/INGREDIENT]
839	PERIPHERAL BLOOD MONONUCLEAR CELLS [CHEMICAL/INGREDIENT]
840	INACTIVATED INFLUENZA A VIRUS VACCINE [EPC]
841	INFLUENZA VACCINES [CHEMICAL/INGREDIENT]
842	NON-STANDARDIZED FEATHER ALLERGENIC EXTRACT [EPC]
843	FEATHERS [CHEMICAL/INGREDIENT]
844	SILK [CHEMICAL/INGREDIENT]
845	SKIN TEST ANTIGEN [EPC]
846	TUBERCULOSIS SKIN TEST [EPC]
847	BACTERIAL [CHEMICAL/INGREDIENT]
848	HUMAN C1 ESTERASE INHIBITOR [EPC]
849	DECREASED VASCULAR PERMEABILITY [PE]
850	KALLIKREIN INHIBITORS [MOA]
851	INTERFERON GAMMA [EPC]
852	INTERFERON-GAMMA [CHEMICAL/INGREDIENT]
853	INACTIVATED JAPANESE ENCEPHALITIS VIRUS VACCINE [EPC]
854	JAPANESE ENCEPHALITIS VACCINES [CHEMICAL/INGREDIENT]
855	ALLOGENEIC CULTURED CELL SCAFFOLD [EPC]
856	COLLAGEN [CHEMICAL/INGREDIENT]
857	TISSUE SCAFFOLDS [CHEMICAL/INGREDIENT]
858	ALLOGENEIC [CHEMICAL/INGREDIENT]
859	FIBROBLASTS [CHEMICAL/INGREDIENT]
860	KERATINOCYTES [CHEMICAL/INGREDIENT]
861	RECOMBINANT ANTITHROMBIN [EPC]
862	LIVE ATTENUATED INFLUENZA A VIRUS VACCINE [EPC]
863	INTERFERON-BETA [CHEMICAL/INGREDIENT]
864	RECOMBINANT HUMAN INTERFERON BETA [EPC]
865	RECOMBINANT PROTEINS [CHEMICAL/INGREDIENT]
866	PARATHYROID HORMONE [EPC]
867	SCLEROSING AGENT [EPC]
868	SCLEROSING ACTIVITY [MOA]
869	VASCULAR SCLEROSING ACTIVITY [PE]
870	INACTIVATED BORDETELLA PERTUSSIS VACCINE [EPC]
871	PERTUSSIS VACCINE [CHEMICAL/INGREDIENT]
872	INACTIVATED POLIOVIRUS VACCINE [EPC]
873	POLIOVIRUS VACCINE [CHEMICAL/INGREDIENT]
874	INACTIVATED MENINGOCOCCAL VACCINE [EPC]
875	MENINGOCOCCAL VACCINES [CHEMICAL/INGREDIENT]
876	INACTIVATED SALMONELLA TYPHI VACCINE [EPC]
877	TYPHOID [CHEMICAL/INGREDIENT]
878	VI POLYSACCHARIDE VACCINE
879	TYPHOID [CHEMICAL/INGREDIENT]
880	LIVE ATTENUATED YELLOW FEVER VIRUS VACCINE [EPC]
881	YELLOW FEVER VACCINE [CHEMICAL/INGREDIENT]
882	NON-STANDARDIZED BACTERIAL ALLERGENIC EXTRACT [EPC]
883	BACTERIAL PROTEINS [CHEMICAL/INGREDIENT]
884	NON-STANDARDIZED ANIMAL HAIR ALLERGENIC EXTRACT [EPC]
885	DECREASED B LYMPHOCYTE ACTIVATION [PE]
886	B LYMPHOCYTE STIMULATOR-SPECIFIC INHIBITOR [EPC]
887	B LYMPHOCYTE STIMULATOR-DIRECTED ANTIBODY INTERACTIONS [MOA]
888	METHYLATED SULFONAMIDE ANTIBACTERIAL [EPC]
889	METHYLATED SULFONAMIDES [CHEMICAL/INGREDIENT]
890	SELECTIVE PROGESTERONE RECEPTOR MODULATORS [MOA]
891	PROGESTERONE AGONIST/ANTAGONIST [EPC]
892	LIVE VACCINIA VIRUS VACCINE [EPC]
893	SMALLPOX VACCINE [CHEMICAL/INGREDIENT]
894	CELL DEATH INDUCER [EPC]
895	INCREASED CELLULAR DEATH [PE]
896	ANTI-IGE [EPC]
897	DECREASED IGE ACTIVITY [PE]
898	IGE-DIRECTED ANTIBODY INTERACTIONS [MOA]
899	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR INHIBITORS [MOA]
900	VASCULAR ENDOTHELIAL GROWTH FACTOR-DIRECTED ANTIBODY [EPC]
901	VASCULAR ENDOTHELIAL GROWTH FACTOR-DIRECTED ANTIBODY INTERACTIONS [MOA]
902	DEOXYRIBONUCLEASE I [CHEMICAL/INGREDIENT]
903	RECOMBINANT HUMAN DEOXYRIBONUCLEASE 1 [EPC]
904	INTERLEUKIN 6 RECEPTOR ANTAGONISTS [MOA]
905	INTERLEUKIN-6 RECEPTOR ANTAGONIST [EPC]
906	HEDGEHOG PATHWAY INHIBITOR [EPC]
907	SMOOTHENED RECEPTOR ANTAGONISTS [MOA]
908	HER2 RECEPTOR ANTAGONIST [EPC]
909	HER2/NEU/CERBB2 ANTAGONISTS [MOA]
910	GUANYLATE CYCLASE STIMULATORS [MOA]
911	SOLUBLE GUANYLATE CYCLASE STIMULATOR [EPC]
912	ANTIHELMINTHIC [EPC]
913	GLYCOSAMINOGLYCAN [EPC]
914	GLYCOSAMINOGLYCANS [CHEMICAL/INGREDIENT]
915	CD30-DIRECTED ANTIBODY INTERACTIONS [MOA]
916	CD30-DIRECTED IMMUNOCONJUGATE [EPC]
917	IMMUNOCONJUGATES [CHEMICAL/INGREDIENT]
918	CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR POTENTIATOR [EPC]
919	CHLORIDE CHANNEL ACTIVATION POTENTIATORS [MOA]
920	MACROLIDE ANTIBACTERIAL [EPC]
921	CALCIUM-SENSING RECEPTOR AGONIST [EPC]
922	INCREASED CALCIUM-SENSING RECEPTOR SENSITIVITY [MOA]
923	CARBAMOYL PHOSPHATE SYNTHETASE 1 ACTIVATOR [EPC]
924	CARBAMOYL PHOSPHATE SYNTHETASE 1 ACTIVATORS [MOA]
925	AMPHENICOL-CLASS ANTIBACTERIAL [EPC]
926	AMPHENICOLS [CHEMICAL/INGREDIENT]
927	WASP VENOMS [CHEMICAL/INGREDIENT]
928	ALPHA-GLUCOSIDASES [CHEMICAL/INGREDIENT]
929	HYDROLYTIC LYSOSOMAL GLYCOSAMINOGLYCAN-SPECIFIC ENZYME [EPC]
930	BRADYKININ B2 RECEPTOR ANTAGONIST [EPC]
931	BRADYKININ B2 RECEPTOR ANTAGONISTS [MOA]
932	URATE OXIDASE [CHEMICAL/INGREDIENT]
933	URIC ACID-SPECIFIC ENZYME [EPC]
934	ASPARAGINASE [CHEMICAL/INGREDIENT]
935	ASPARAGINE-SPECIFIC ENZYME [EPC]
936	ANTI-ANGINAL [EPC]
937	HEPARIN BINDING ACTIVITY [MOA]
938	HEPARIN REVERSAL AGENT [EPC]
939	ACTINOMYCIN [EPC]
940	FREE RADICAL SCAVENGING ACTIVITY [MOA]
941	THROMBOPOIETIN RECEPTOR AGONIST [EPC]
942	RANK LIGAND INHIBITOR [EPC]
943	RANK LIGAND BLOCKING ACTIVITY [MOA]
944	EPIDERMAL GROWTH FACTOR RECEPTOR ANTAGONIST [EPC]
945	ADENOSINE DEAMINASE [CHEMICAL/INGREDIENT]
946	BOVINE INTESTINAL ADENOSINE DEAMINASE [EPC]
947	CYTOCHROME P450 17A1 INHIBITORS [MOA]
948	CYTOCHROME P450 17A1 INHIBITOR [EPC]
949	INTERLEUKIN-6 ANTAGONIST [EPC]
950	INTERLEUKIN-6 ANTAGONISTS [MOA]
951	THYROID STIMULATING HORMONE [EPC]
952	THYROTROPIN [CHEMICAL/INGREDIENT]
953	HYDROLYTIC LYSOSOMAL NEUTRAL GLYCOSPHINGOLIPID-SPECIFIC ENZYME [EPC]
954	HYDROLYTIC LYSOSOMAL GLYCOGEN-SPECIFIC ENZYME [EPC]
955	CD52-DIRECTED ANTIBODY INTERACTIONS [MOA]
956	CD52-DIRECTED CYTOLYTIC ANTIBODY [EPC]
957	PYRIMIDINE SYNTHESIS INHIBITOR [EPC]
958	DIHYDROOROTATE DEHYDROGENASE INHIBITORS [MOA]
959	GLUCOSYLCERAMIDE SYNTHASE INHIBITOR [EPC]
960	GLUCOSYLCERAMIDE SYNTHASE INHIBITORS [MOA]
961	AUTOLOGOUS CULTURED CELL [EPC]
962	CHONDROCYTES [CHEMICAL/INGREDIENT]
963	BISMUTH [CHEMICAL/INGREDIENT]
964	BISMUTH [EPC]
965	INTEGRIN RECEPTOR ANTAGONIST [EPC]
966	INTEGRIN RECEPTOR ANTAGONISTS [MOA]
967	CARBON RADIOISOTOPES [CHEMICAL/INGREDIENT]
968	HELICOBACTER PYLORI DIAGNOSTIC [EPC]
969	RADIOACTIVE TRACERS [CHEMICAL/INGREDIENT]
970	DECREASED IMMUNOLOGICALLY ACTIVE MOLECULE ACTIVITY [PE]
971	THALIDOMIDE ANALOG [EPC]
972	FUNGAL [CHEMICAL/INGREDIENT]
973	CD3 BLOCKER IMMUNOSUPPRESSANT [EPC]
974	CD3 RECEPTOR ANTAGONISTS [MOA]
975	CD3-DIRECTED ANTIBODY INTERACTIONS [MOA]
976	DIARYLQUINOLINE ANTIMYCOBACTERIAL [EPC]
977	DIARYLQUINOLINES [CHEMICAL/INGREDIENT]
978	ANTIBODIES
979	MONOCLONAL [CHEMICAL/INGREDIENT]
980	FUSION PROTEIN INHIBITORS [MOA]
981	RESPIRATORY SYNCYTIAL VIRUS ANTI-F PROTEIN MONOCLONAL ANTIBODY [EPC]
982	ANGIOTENSIN 2 TYPE 1 RECEPTOR ANTAGONISTS [MOA]
983	CHOLINESTERASE REACTIVATOR [EPC]
984	CHOLINESTERASE REACTIVATORS [MOA]
985	STREPTOGRAMIN ANTIBACTERIAL [EPC]
986	STREPTOGRAMINS [CHEMICAL/INGREDIENT]
987	ANTILEISHMANIAL [EPC]
988	ENDOTHELIN RECEPTOR ANTAGONIST [EPC]
989	ENDOTHELIN RECEPTOR ANTAGONISTS [MOA]
990	HEPATITIS C VIRUS NS5A INHIBITOR [EPC]
991	NONCOMPETITIVE AMPA GLUTAMATE RECEPTOR ANTAGONIST [EPC]
992	AMPA RECEPTOR ANTAGONISTS [MOA]
993	SEROTONIN-2C RECEPTOR AGONIST [EPC]
994	SEROTONIN 2C RECEPTOR AGONISTS [MOA]
995	CD25-DIRECTED CYTOTOXIN [EPC]
996	DIPHTHERIA TOXIN [CHEMICAL/INGREDIENT]
997	PROTEASOME INHIBITOR [EPC]
998	PROTEASOME INHIBITORS [MOA]
999	DEOXYURIDINE [CHEMICAL/INGREDIENT]
1000	METHYLATING ACTIVITY [MOA]
1001	METHYLATING AGENT [EPC]
1002	LIVE ATTENUATED BACILLUS ANTHRACIS VACCINE [EPC]
1003	ANTHRAX VACCINES [CHEMICAL/INGREDIENT]
1004	VASODILATOR [EPC]
1005	NON-STANDARDIZED ANIMAL DANDER ALLERGENIC EXTRACT [EPC]
1006	QUATERNARY AMMONIUM COMPOUNDS [CHEMICAL/INGREDIENT]
1007	NATRIURETIC PEPTIDE [EPC]
1008	NATRIURETIC PEPTIDES [CHEMICAL/INGREDIENT]
1009	PROSTACYCLINE [EPC]
1010	ANTIDIURETIC HORMONE ANTAGONISTS [MOA]
1011	VASOPRESSIN ANTAGONIST [EPC]
1012	INACTIVATED INFLUENZA B VIRUS VACCINE [EPC]
1013	ANTIVENIN [EPC]
1014	VENOM NEUTRALIZATION [MOA]
1015	ANTIVENINS [CHEMICAL/INGREDIENT]
1016	HYDROXYPHENYL-PYRUVATE DIOXYGENASE INHIBITOR [EPC]
1017	HYDROXYPHENYLPYRUVATE DIOXYGENASE INHIBITORS [MOA]
1018	FIBROBLAST GROWTH FACTOR 7 [CHEMICAL/INGREDIENT]
1019	INCREASED EPITHELIAL PROLIFERATION [PE]
1020	MUCOCUTANEOUS EPITHELIAL CELL GROWTH FACTOR [EPC]
1021	INTERLEUKIN 1 RECEPTOR ANTAGONISTS [MOA]
1022	INTERLEUKIN-1 RECEPTOR ANTAGONIST [EPC]
1023	HER1 ANTAGONISTS [MOA]
1024	LEPTIN ANALOG [EPC]
1025	ANALOGS/DERIVATIVES [CHEMICAL/INGREDIENT]
1026	LEPTIN [CHEMICAL/INGREDIENT]
1027	VESICULAR MONOAMINE TRANSPORTER 2 INHIBITOR [EPC]
1028	VESICULAR MONOAMINE TRANSPORTER 2 INHIBITORS [MOA]
1029	INCREASED BLOOD PRESSURE [PE]
1030	HUMAN ANTIHEMOPHILIC FACTOR [EPC]
1031	FACTOR VIII [CHEMICAL/INGREDIENT]
1032	INCREASED PLATELET AGGREGATION [PE]
1033	VON WILLEBRAND FACTOR [CHEMICAL/INGREDIENT]
1034	SUCROSE-SPECIFIC ENZYME [EPC]
1035	PHENYLALANINE HYDROXYLASE ACTIVATOR [EPC]
1036	BACTERIAL NEUROTOXIN NEUTRALIZATION [MOA]
1037	ANTITOXINS [CHEMICAL/INGREDIENT]
1038	CENTRAL NERVOUS SYSTEM DEPRESSANT [EPC]
1039	DECREASED CENTRAL NERVOUS SYSTEM ORGANIZED ELECTRICAL ACTIVITY [PE]
1040	OLIGONUCLEOTIDES [CHEMICAL/INGREDIENT]
1041	APTAMERS
1042	NUCLEOTIDE [CHEMICAL/INGREDIENT]
1043	ADRENAL STEROID SYNTHESIS INHIBITOR [EPC]
1044	ADRENAL STEROID SYNTHESIS INHIBITORS [MOA]
1045	PROGESTATIONAL HORMONE RECEPTOR ANTAGONISTS [MOA]
1046	PROGESTIN ANTAGONIST [EPC]
1047	MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN INHIBITOR [EPC]
1048	MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN INHIBITORS [MOA]
1049	ALLOGENEIC CORD BLOOD HEMATOPOIETIC PROGENITOR CELL THERAPY [EPC]
1050	HEMATOPOIETIC STEM CELLS [CHEMICAL/INGREDIENT]
1051	INTERLEUKIN-17A ANTAGONIST [EPC]
1052	INTERLEUKIN-17A ANTAGONISTS [MOA]
1053	SLAMF7-DIRECTED IMMUNOSTIMULATORY ANTIBODY [EPC]
1054	SLAMF7-DIRECTED ANTIBODY INTERACTIONS [MOA]
1055	UGT1A1 INHIBITORS [MOA]
1056	UDP GLUCURONOSYLTRANSFERASES INHIBITORS [MOA]
1057	GAMMA-CYCLODEXTRINS [CHEMICAL/INGREDIENT]
1058	UGT1A3 INHIBITORS [MOA]
1059	UGT1A4 INHIBITORS [MOA]
1060	UGT1A6 INHIBITORS [MOA]
1061	UGT1A9 INHIBITORS [MOA]
1062	UGT2B7 INHIBITORS [MOA]
1063	UGT2B15 INHIBITORS [MOA]
1064	CYCLOOXYGENASE INHIBITOR [EPC]
1065	VASOCONSTRICTOR [EPC]
1066	VASOCONSTRICTION [PE]
1067	IMIDAZOLINES [CHEMICAL/INGREDIENT]
1068	PCSK9 INHIBITOR [EPC]
1069	PCSK9 INHIBITORS [MOA]
1070	OXIDATION-REDUCTION AGENT [EPC]
1071	OXIDATION-REDUCTION ACTIVITY [MOA]
1072	INHIBITION SMALL INTESTINE FLUID/ELECTROLYTE ABSORPTION [PE]
1073	KINASE INHIBITORS [MOA]
1074	UDP GLUCURONOSYLTRANSFERASES INDUCERS [MOA]
1075	BCL-2 INHIBITOR [EPC]
1076	NEPRILYSIN INHIBITOR [EPC]
1077	NEPRILYSIN INHIBITORS [MOA]
1078	INHIBITION GASTRIC ACID SECRETION [PE]
1079	INTERLEUKIN-5 ANTAGONIST [EPC]
1080	INTERLEUKIN-5 ANTAGONISTS [MOA]
1081	LIPID EMULSION [EPC]
1082	LIPIDS [CHEMICAL/INGREDIENT]
1083	POLY(ADP-RIBOSE) POLYMERASE INHIBITOR [EPC]
1084	POLY(ADP-RIBOSE) POLYMERASE INHIBITORS [MOA]
1085	URATE TRANSPORTER 1 INHIBITOR [EPC]
1086	URATE TRANSPORTER 1 INHIBITORS [MOA]
1087	HUMANIZED MONOCLONAL ANTIBODY FRAGMENT [EPC]
1088	MONOCLONAL
1089	HUMANIZED [CHEMICAL/INGREDIENT]
1090	NOREPINEPHRINE RELEASING AGENT [EPC]
1091	PROTEOLYTIC ENZYME [EPC]
1092	PEPTIDE HYDROLASES [CHEMICAL/INGREDIENT]
1093	HYDROLYTIC LYSOSOMAL CHOLESTERYL ESTER-SPECIFIC ENZYME [EPC]
1094	HYDROLYTIC LYSOSOMAL TRIACYLGLYCEROL-SPECIFIC ENZYME [EPC]
1095	LYSOSOMAL ACID CHOLESTEROL ESTERASE [CHEMICAL/INGREDIENT]
1096	TISSUE-NONSPECIFIC ALKALINE PHOSPHATASE [EPC]
1097	ALKALINE PHOSPHATASE [CHEMICAL/INGREDIENT]
1098	P-GLYCOPROTEIN INDUCERS [MOA]
1099	ANTHRAX PROTECTIVE ANTIGEN-DIRECTED ANTIBODY [EPC]
1100	ANTHRAX PROTECTIVE ANTIGEN-DIRECTED ANTIBODY INTERACTIONS [MOA]
1101	MULTIDRUG AND TOXIN EXTRUSION TRANSPORTER 1 INHIBITORS [MOA]
1102	PYRIDONE [EPC]
1103	PYRIDONES [CHEMICAL/INGREDIENT]
1104	ANTIBODIES [CHEMICAL/INGREDIENT]
1105	RADIOACTIVE ALPHA-PARTICLE EMITTING THERAPEUTIC AGENT [EPC]
1106	ALPHA-PARTICLE EMITTING ACTIVITY [MOA]
1107	EPOXIDE HYDROLASE INHIBITORS [MOA]
1108	CARBOXYPEPTIDASE [EPC]
1109	CARBOXYPEPTIDASES [CHEMICAL/INGREDIENT]
1110	CYTOCHROME P450 1A INDUCERS [MOA]
1111	LIPOGLYCOPEPTIDE ANTIBACTERIAL [EPC]
1112	LIPOGLYCOPEPTIDES [CHEMICAL/INGREDIENT]
1113	POTASSIUM BINDER [EPC]
1114	POTASSIUM ION BINDING ACTIVITY [MOA]
1115	LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 ANTAGONIST [EPC]
1116	LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 ANTAGONISTS [MOA]
1117	LIVE ATTENUATED SALMONELLA TYPHI VACCINE [EPC]
1118	HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED CHANNEL BLOCKER [EPC]
1119	HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED CHANNEL ANTAGONISTS [MOA]
1120	CD38-DIRECTED CYTOLYTIC ANTIBODY [EPC]
1121	CD38-DIRECTED ANTIBODY INTERACTIONS [MOA]
1122	APOLIPOPROTEIN B-100 SYNTHESIS INHIBITOR [EPC]
1123	ANTISENSE OLIGONUCLEOTIDE [EPC]
1124	OLIGONUCLEOTIDES
1125	ANTISENSE [CHEMICAL/INGREDIENT]
1126	CYTOLYTIC AGENT [EPC]
1127	DECREASED CELL MEMBRANE INTEGRITY [PE]
1128	MU-OPIOID RECEPTOR AGONIST [EPC]
1129	OPIOID MU-RECEPTOR AGONISTS [MOA]
1130	HEPATITIS C VIRUS NUCLEOTIDE ANALOG NS5B POLYMERASE INHIBITOR [EPC]
1131	RNA REPLICASE INHIBITORS [MOA]
1132	ORGANIC ANION TRANSPORTING POLYPEPTIDE 2B1 INHIBITORS [MOA]
1133	THYMIDINE PHOSPHORYLASE INHIBITOR [EPC]
1134	THYMIDINE PHOSPHORYLASE INHIBITORS [MOA]
1135	PROSTACYCLIN RECEPTOR AGONIST [EPC]
1136	PROSTACYCLIN RECEPTOR AGONISTS [MOA]
1137	GLYCOLIPID DISIALOGANGLIOSIDE-DIRECTED ANTIBODY [EPC]
1138	GLYCOLIPID DISIALOGANGLIOSIDE-DIRECTED ANTIBODY INTERACTIONS [MOA]
1139	GLP-2 ANALOG [EPC]
1140	GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONISTS [MOA]
1141	GLUCAGON-LIKE PEPTIDE 2 [CHEMICAL/INGREDIENT]
1142	PYRIMIDINE ANALOG [EPC]
1143	PYRIMIDINES [CHEMICAL/INGREDIENT]
1144	FARNESOID X RECEPTOR AGONIST [EPC]
1145	FARNESOID X RECEPTOR AGONISTS [MOA]
1146	PORPHYRIN PRECURSOR [EPC]
1147	PORPHYRINOGENS [CHEMICAL/INGREDIENT]
